Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three batches of Japanese encephalitis vaccine IC51 (JE-PIV)
2006-002076-18Phase 3Completed
- Sponsor
- Intercell AG
- Start
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of japanese encephalitis vaccine (inactivated, adsorbed) in Japanese encephalitis (JE) (3 arms), sponsored by Intercell AG. Primary endpoint: Geometric Mean Titers (GMT) for anti-JEV neutralizing antibody at day 56. Started May 2006; status: completed.
02
Drugs
japanese encephalitis vaccine (inactivated, adsorbed)
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2006-002076-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002076-18.